| Financial Year |
March 31 2023 |
| Monetary Funds |
4,410,738,704.80 |
| Held-for-trading Financial Assets |
1,004,046,266.91 |
| Notes Receivable |
62,926,729.35 |
| Accounts Receivable |
783,903,295.28 |
| Advances to Suppliers |
584,262,596.18 |
| Other Receivables |
224,553,116.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,857,805,721.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
538,239,485.71 |
| Total Current Assets |
14,161,758,763.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
724,198,845.73 |
| Investment Properties |
118,547,500.71 |
| Fixed Assetes |
14,743,262,103.05 |
| Under-construction Projects |
4,275,999,634.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,637,936,570.42 |
| R&D expenses |
-- |
| Goodwill |
140,882,354.35 |
| Long-Term Deferred and Prepaid Expenses |
22,537,857.47 |
| Deferred Income Tax Assets |
448,549,216.64 |
| Other Non-Current Assets |
224,342,826.22 |
| Sub-Total of Non-Current Assets |
26,685,182,240.97 |
| Total Assets |
40,846,941,004.11 |
| Short-Term Loans |
7,438,410,188.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,992,232.58 |
| Accounts Payable |
1,727,949,787.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
361,680,318.15 |
| Taxes Payable |
121,933,678.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,831,541,743.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,586,484,571.39 |
| Other Current Liabilities |
88,143,573.02 |
| Sub-Total of Current Liabilities |
13,508,335,845.65 |
| Long-term Loans |
2,719,764,450.96 |
| Bonds Payable |
2,777,842,288.32 |
| Long-Term Accounts Payable |
1,623,717,489.56 |
| Special Payable |
-- |
| Estimatied Liabilities |
275,253,646.00 |
| Deferred Income Tax Liabilities |
853,394,370.60 |
| Other Non-Current Liabilities |
80,239,266.05 |
| Sub-Total of Non-Current Liabilities |
8,900,421,294.90 |
| Total Liabilities |
22,408,757,140.55 |
| Paid-In Capital(Or Share Stock) |
3,737,543,730.00 |
| Capital Surplus |
2,279,321,154.87 |
| Surplus Reserve |
1,233,753,775.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,663,473,864.88 |
| Minority Stockholder's Interest |
3,531,693,504.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,906,490,359.20 |
| Owner's Equity（Stockholder's Equity） |
18,438,183,863.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
40,846,941,004.11 |
